Final report on clinical study and value of MRF to predict MVI.

This final report after the 6 months of allowing for final data analysis will show the value MRF provides for predicting the presenceabsence of MVI in HCC This report will also refer to the resultsobtained via ScreenCell and establish whether a combination of CTC derived information plus MRF derived biomarkers has the potential to further improve the prediction of MVI